Results
Seventy three participants (37 patients in the empagliflozin group and 36 patients in the pioglitazone group) were enrolled to the two study arms. Data from these patients were used for an intention to treatment analysis. Three patients (one in the pioglitazone group and two in the empagliflozin group) did not complete the study due to non-adherence to the study medications. The flowchart of patient enrollment is shown in Supplement 
Baseline characteristics of the participants7.9 (1.5–24)8.0 (0.5–30)